戻る
Akeso, Inc. (9926.HK)価格
9926.HK 株価推移チャート
AKESO (9926.HK)
Akeso, Inc.
HK$121
-1.06%
$-1.29
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$121.9
始値
$122.3
当日レンジ
$118.6 - $122.5
52週レンジ
$54 - $179
取引高
5.1M
平均取引高
7.0M
1株当たり利益(TTM)
-1.07
配当利回り
--
時価総額
$111.4B
AKESOとは何ですか？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
